Search
by Eric Sagonowsky | Fiecepharma.com
- 2 min
The top 10 drugs of 2024
EvaluatePharma analysts predict AbbVie's Humira will top pharma's sales charts in 2024, followed by Merck's Keytruda and Celgene's Revlimid. (Pixabay) Even as many things change in the drug industry, at least one fact should stay the same in the coming years, according to analysts at EvaluatePharma. AbbVie's megablockbuster Humira will lead the world's drug sales charts in 2024, according to a new report, representing a record-breaking run that has lifted the company's fortun
selected & edited by #pharmanaming.com
- 1 min
FDA Draft Guidance Requiring Distinct Naming for Biosimilars
Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency ATLANTA – The American College of Rheumatology (ACR) today praised the Food and Drug Administration (FDA) for issuing draft guidance requiring separate and distinct names for biosimilars and biologic therapies. The guidance, “Nonproprietary Naming of Biologic Products,” would designate separate and distinct, non-proprietary names for originator biologic products, related biological products, and biosimi
reprinted on DrugPatentWatch.com from the book
- 2 min
A drug by any other name would work just as well — making sense of drug names
How are drugs named, and how do names aid in prescription and generic substitution? In William Shakespeare's play Romeo and Juliet, Juliet uses the phrase "A rose by any other name would smell just as sweet" to argue that it does not matter that Romeo is from her family rival's house of Montague. Likewise, drug naming is used to indicate that drugs from different companies have common ingredients and efficacy. The following excerpt, reprinted with permission from Building Bio
Via: NY Times
- 3 min
FDA Approves First Sensor Pill to Alert Doctors When It’s Ingested
The U.S. Food and Drug Administration (Silver Spring, MD) has approved a pill that includes a sensor that digitally tracks if patients have ingested it. The United States Federal Drug and Food Administration (FDA) just approved a pill with sensors for the first time. Anti-psychotic drug Abilify MyCite which has a “digital ingestion tracking system” to monitor if the drug was actually ingested has been approved for sale by the administration. In a press release to online media
